We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$77.2B
AUM Growth
+$3.78B
Cap. Flow
+$3.39B
Cap. Flow %
4.39%
Top 10 Hldgs %
11.56%
Holding
4,729
New
599
Increased
1,385
Reduced
1,503
Closed
674

Top Buys

Rank Stock Value
1
FWONK icon
Liberty Media Series C
FWONK
+$430M
2
BABA icon
Alibaba
BABA
+$364M
3
HPQ icon
HP
HPQ
+$298M
4
PFE icon
Pfizer
PFE
+$258M
5
BKNG icon
Booking.com
BKNG
+$244M

Sector Composition

Rank Sector Weight
1 Technology 8.89%
2 Consumer Discretionary 8.28%
3 Energy 7.75%
4 Healthcare 6.77%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORMP icon
3926
Oramed Pharmaceuticals
ORMP
$165M
$137K ﹤0.01%
17,003
-5,041
-23% -$44.8K
EGO icon
3927
PUT
Eldorado Gold
EGO
$8.31B
$135K ﹤0.01%
4,000
ANV
3928
DELISTED
Allied Nevada Gold Corp
ANV
$134K ﹤0.01%
40,525
+598
+1% +$2.06K
EPAX
3929
DELISTED
Ambassadors Group Inc
EPAX
$133K ﹤0.01%
35,920
ELNK
3930
DELISTED
EarthLink Holdings Corp.
ELNK
$131K ﹤0.01%
+38,370
New +$151K
PSUN
3931
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
$129K ﹤0.01%
71,280
+22,509
+46% +$46.9K
NWBO
3932
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$129K ﹤0.01%
25,725
-115,672
-82% -$711K
MIG
3933
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
$128K ﹤0.01%
21,902
-5,691
-21% -$35.7K
CPE
3934
DELISTED
Callon Petroleum Company
CPE
$127K ﹤0.01%
1,440
-1,108
-43% -$113K
AMD icon
3935
CALL
Advanced Micro Devices
AMD
$851B
$126K ﹤0.01%
36,900
+16,200
+78% +$65.6K
CLD
3936
CALL
DELISTED
Cloud Peak Energy Inc
CLD
$126K ﹤0.01%
+10,000
New +$151K
EBSB
3937
DELISTED
Meridian Bancorp, Inc.
EBSB
$125K ﹤0.01%
+11,793
New +$126K
HZNP
3938
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$123K ﹤0.01%
10,000
-80,000
-89% -$930K
AUQ
3939
DELISTED
AURICO GOLD INC COM
AUQ
$123K ﹤0.01%
35,300
+3,456
+11% +$14.2K
PERI icon
3940
Perion Network
PERI
$367M
$122K ﹤0.01%
7,304
-13,674
-65% -$313K
CCXI
3941
DELISTED
ChemoCentryx, Inc.
CCXI
$121K ﹤0.01%
26,799
+12,298
+85% +$65K
TCRT icon
3942
Alaunos Therapeutics
TCRT
$4.74M
$120K ﹤0.01%
304
-244
-45% -$118K
LSTA icon
3943
Lisata Therapeutics
LSTA
$15.2M
$115K ﹤0.01%
138
-158
-53% -$138K
SKYW icon
3944
Skywest
SKYW
$4.11B
$115K ﹤0.01%
+14,739
New +$149K
WT icon
3945
PUT
WisdomTree
WT
$2.97B
$114K ﹤0.01%
10,000
-55,900
-85% -$636K
QTWW
3946
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
$114K ﹤0.01%
+30,729
New +$151K
EGO icon
3947
Eldorado Gold
EGO
$8.31B
$110K ﹤0.01%
+3,278
New +$126K
NCIT
3948
DELISTED
NCI, Inc.
NCIT
$110K ﹤0.01%
11,544
HCT
3949
DELISTED
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
$109K ﹤0.01%
10,387
-268,854
-96% -$2.89M
KWK
3950
DELISTED
QUICKSILVER RESOURCES INC
KWK
$108K ﹤0.01%
179,272
+102,370
+133% +$155K

Similar funds

D.E. Shaw & Co's Q3 2014 Portfolio in Review

As of Q3 2014, D.E. Shaw & Co held 4,729 positions worth $77.2B, up 5.1% from $73.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co deployed $3.39B of net new capital in Q3 2014, opening 599 new positions and adding to 1,385 existing holdings. Its largest new stake was Liberty Media Series C: 16,804,239 shares worth $422M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Liberty Media Series A, an estimated $321M trimmed.

  • D.E. Shaw & Co's largest Q3 2014 buy was Liberty Media Series C: 16,804,239 shares worth $422M.
  • D.E. Shaw & Co added most to HP in Q3 2014, an estimated $298M increase.
  • D.E. Shaw & Co's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $321M.
  • D.E. Shaw & Co fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $602M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $77.2B portfolio in Q3 2014.
  • D.E. Shaw & Co opened 599 new positions and closed 674 in Q3 2014.
  • D.E. Shaw & Co's portfolio value rose 5.1% quarter-over-quarter to $77.2B.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.